Hyperbaric Chamber

Hyperbaric oxygen therapy (HBOT) has gained attention as a potential treatment option for various medical conditions and injuries, including orthopedic and rheumatological diseases. While the results of studies investigating HBOT’s effectiveness are controversial, there is emerging evidence supporting its use in certain conditions. This article reviews the efficacy and limitations of HBOT in orthopedic and rheumatologic patients.

Introduction:

Hyperbaric oxygen therapy (HBOT) involves the administration of pure oxygen in a pressurized environment, typically in a hyperbaric chamber. HBOT has been extensively studied and utilized as a primary or adjunctive treatment for various conditions such as traumatic ischemia, necrotizing soft tissue injuries, non-healing ulcers, and osteoradionecrosis. However, its role in orthopedic and rheumatological diseases remains a topic of debate.

HBOT in Fibromyalgia:

Hyperbaric oxygen therapy (HBOT) involves the administration of pure oxygen in a pressurized environment, typically in a hyperbaric chamber. HBOT has been extensively studied and utilized as a primary or adjunctive treatment for various conditions such as traumatic ischemia, necrotizing soft tissue injuries, non-healing ulcers, and osteoradionecrosis. However, its role in orthopedic and rheumatological diseases remains a topic of debate.

HBOT in Orthopedics:

In the field of orthopedics, the evidence supporting the use of HBOT is limited and often conflicting. While some studies have reported positive outcomes, there is currently insufficient evidence to support or reject the use of HBOT in expediting the healing process or treating established non-union fractures. Further research is necessary to determine the optimal protocols and patient selection criteria for orthopedic conditions.

HBOT in Rheumatological Diseases:

Hyperbaric oxygen therapy has demonstrated anti-inflammatory and oxygenatory effects in patients with primary or secondary vasculitis, a group of rheumatological diseases characterized by blood vessel inflammation. By increasing the availability of oxygen to affected tissues, HBOT may aid in reducing inflammation and promoting healing. However, more extensive research is needed to fully understand the mechanisms of action and establish the clinical efficacy of HBOT in rheumatological diseases.

Limitations and Considerations:

While HBOT shows promise in certain orthopedic and rheumatological conditions, there are several limitations and considerations to be addressed. The availability of hyperbaric chambers, the cost of treatment, and the need for specialized facilities and trained personnel can limit its widespread use. Additionally, the optimal treatment protocols, such as the number and duration of sessions, remain uncertain and may vary depending on the specific condition being treated.

Conclusion:

Hyperbaric oxygen therapy holds potential as a treatment modality for orthopedic and rheumatological diseases. While the evidence supporting its efficacy is still limited and controversial, HBOT has shown promise in managing fibromyalgia symptoms and exerting anti-inflammatory effects in vasculitis patients. Further research is needed to better understand the mechanisms of action, establish standardized protocols, and identify specific patient populations that may benefit the most from HBOT in orthopedics and rheumatology.

Call for an appointment

Log-in to